Medipharm Labs Corp
TSX:LABS

Watchlist Manager
Medipharm Labs Corp Logo
Medipharm Labs Corp
TSX:LABS
Watchlist
Price: 0.07 CAD -6.67% Market Closed
Market Cap: 29.1m CAD

Intrinsic Value

LABS doesn't have a meaningful market cap.

The intrinsic value of one LABS stock under the Base Case scenario is 0.1 CAD. Compared to the current market price of 0.07 CAD, Medipharm Labs Corp is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LABS Intrinsic Value
0.1 CAD
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Medipharm Labs Corp

Valuation History Unavailable

Historical valuation for LABS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LABS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Medipharm Labs Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medipharm Labs Corp

Current Assets 31.8m
Cash & Short-Term Investments 8.4m
Receivables 7.8m
Other Current Assets 15.6m
Non-Current Assets 20.3m
PP&E 18.8m
Intangibles 809k
Other Non-Current Assets 635k
Efficiency

Free Cash Flow Analysis
Medipharm Labs Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medipharm Labs Corp

Revenue
43m CAD
Cost of Revenue
-30m CAD
Gross Profit
13m CAD
Operating Expenses
-21.9m CAD
Operating Income
-8.8m CAD
Other Expenses
1.4m CAD
Net Income
-7.5m CAD
Fundamental Scores

LABS Profitability Score
Profitability Due Diligence

Medipharm Labs Corp's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
Positive 1-Year Revenue Growth
24/100
Profitability
Score

Medipharm Labs Corp's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

LABS Solvency Score
Solvency Due Diligence

Medipharm Labs Corp's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Negative Net Debt
Low D/E
Short-Term Solvency
55/100
Solvency
Score

Medipharm Labs Corp's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LABS Price Targets Summary
Medipharm Labs Corp

There are no price targets for LABS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Medipharm Labs Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for LABS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one LABS stock?

The intrinsic value of one LABS stock under the Base Case scenario is 0.1 CAD.

Is LABS stock undervalued or overvalued?

Compared to the current market price of 0.07 CAD, Medipharm Labs Corp is Undervalued by 28%.

Back to Top